Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

SNT

Senesco (SNT)

Senesco Technologies
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:SNT
DateTimeSourceHeadlineSymbolCompany
05/18/20122:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SNTSenesco Technologies
05/18/20122:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SNTSenesco Technologies
05/18/201211:24AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SNTSenesco Technologies
05/18/201211:23AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SNTSenesco Technologies
05/18/201211:21AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SNTSenesco Technologies
05/18/201211:20AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SNTSenesco Technologies
05/18/201211:19AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SNTSenesco Technologies
05/15/20128:25AMEdgar (US Regulatory)Current report filing (8-K)AMEX:SNTSenesco Technologies
05/15/20127:30AMBusiness WireSenesco Technologies Reports Fiscal 2012 Third Quarter ResultsAMEX:SNTSenesco Technologies
05/14/201212:10PMEdgar (US Regulatory)Quarterly Report (10-Q)AMEX:SNTSenesco Technologies
05/14/20127:30AMBusiness WireSenesco to Present SNS01-T, an eIF5A-based Nanoparticle in a Phase 1b/2a Trial to Treat Multiple Myeloma, is Effective in Mod...AMEX:SNTSenesco Technologies
05/01/20121:15PMEdgar (US Regulatory)Current report filing (8-K)AMEX:SNTSenesco Technologies
05/01/20127:30AMBusiness WireCombination of Lenalidomide and SNS01-T Effective in Cancer ModelAMEX:SNTSenesco Technologies
04/24/20121:08PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)AMEX:SNTSenesco Technologies
04/13/20124:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SNTSenesco Technologies
04/12/201211:55AMEdgar (US Regulatory)Confidential Treatment Order (CT ORDER)AMEX:SNTSenesco Technologies
03/30/20128:57AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SNTSenesco Technologies
03/19/20121:26PMEdgar (US Regulatory)Statement of Ownership (SC 13G)AMEX:SNTSenesco Technologies
03/12/20121:20PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:SNTSenesco Technologies
03/07/20127:37AMEdgar (US Regulatory)Current report filing (8-K)AMEX:SNTSenesco Technologies
03/07/20127:30AMBusiness WireSenesco Adds Additional Clinical Site to Evaluate SNS01-T in Multiple MyelomaAMEX:SNTSenesco Technologies
03/02/20127:42AMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)AMEX:SNTSenesco Technologies
03/02/20127:38AMEdgar (US Regulatory)Current report filing (8-K)AMEX:SNTSenesco Technologies
03/02/20127:30AMBusiness WireSenesco Announces Additional $1.0 Million Equity FinancingAMEX:SNTSenesco Technologies
03/01/20127:43AMEdgar (US Regulatory)Current report filing (8-K)AMEX:SNTSenesco Technologies
03/01/20127:30AMBusiness WireSenesco Adds Second Clinical Site to Evaluate SNS01-T in Multiple MyelomaAMEX:SNTSenesco Technologies
02/24/20121:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SNTSenesco Technologies
02/24/20121:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SNTSenesco Technologies
02/24/20121:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SNTSenesco Technologies
02/24/20121:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SNTSenesco Technologies
 Showing the most relevant articles for your search:AMEX:SNT